Press Releases

NEW YORK and CAESAREA, Israel, Oct. 17, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its third quarter 2019 results on Monday, October 28

DOVER, Delaware, Oct. 17, 2019 /PRNewswire/ -- CarboFix has announced today that the U.S. Food and Drug Administration (FDA) has cleared its CarboClear® Carbon Fiber Vertebral Body Replacement (VBR) System to replace a collapsed, damaged, or unstable vertebral body due to tumor or trauma. The CarboClear® VBR

MILAN and MUNICH and MENLO PARK, Calif., Oct. 17, 2019 /PRNewswire/ -- Breath Therapeutics, a Zambon company, a biopharmaceutical company specializing in advanced inhaled therapeutics for severe respiratory diseases with high unmet medical need, today announced presentations at three upcoming s

PORTLAND, Ore., Oct. 17, 2019 /PRNewswire/ -- Social CBD (www.thesocialcbd.com), the wellness company providing high-quality, lab-tested and certified CBD solutions, to

TUCSON, Ariz., Oct. 17, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that it will report financial results for the third quarter of 2019 after the market close on Thursday, November 7, 2019. The company's management will host a conference call at 4:30 p.m. ET that same da

SAN DIEGO, Oct. 17, 2019 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat serious inflammatory diseases, today announced that it has completed enrollment in RIST4721-201, a Phase 2a study to evaluate the efficacy and safety of RIST4721 in patients with palmoplantar pustulosis.

NEW YORK, Oct. 17, 2019 /PRNewswire/ -- The Rory Staunton Foundation for Sepsis Prevention has been awarded a major federal contract inten

NEW YORK, Oct. 17, 2019 /PRNewswire/ -- The Starr Foundation announced the gift of a $3 million grant to Hospital for Special Surgery (HSS) to establish the C.V. Starr Endowed Chair in Pain Management. This commitment will provide support to enhance pain management research, program development and physician education at HSS.

BEIJING, Oct. 17, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the special committee (the "Special Committee") of the Company's board of directors (the "Board") has retained Duf

ALISO VIEJO, Calif., Oct. 17, 2019 /PRNewswire/ -- Metagenics, Inc., a health sciences company, announced today the release of Hemp Advantage Plus, the third formula launched this year in the Metagenics hemp line. Hemp Advantage Plus combines an organic, broad-spectrum hemp extract with palmitoylethanolamide (PEA) in a patent-pending formula.